News | Focused Ultrasound Therapy | January 27, 2016

New John Grisham Book Promotes Focused Ultrasound

Best-selling author uses book to raise awareness, funds for Focused Ultrasound Foundation

John Grisham book, The Tumor, focused ultrasound

January 27, 2016 — Bestselling author John Grisham has written "The Tumor," a fictional account of how a real medical technology could impact the future of medicine. The short book is about focused ultrasound, a non-invasive therapy with the potential to transform the treatment of a variety of serious medical disorders. The Kindle e-book is available for free on Amazon.

“It’s the most important book I’ve ever written,” said Grisham. “Everyone who is concerned about their health and loved ones should read 'The Tumor' to learn about a breakthrough medical technology. I have found no other cause, issue or charity that can potentially save so many lives.”

"The Tumor" follows the experience of the fictional patient Paul, an otherwise healthy 35-year-old father who is diagnosed with a malignant brain tumor. Despite receiving current state-of-the-art treatment of invasive brain surgery, radiation and chemotherapy, he passes away nine months after his diagnosis.

Grisham then takes readers to an alternate future, where Paul is diagnosed with the same brain tumor at 35 years old in the year 2025. In this future, doctors utilize focused beams of ultrasound energy to destroy Paul’s tumor without cutting into his skull. They then refocus the ultrasound to the surrounding brain to activate nanoparticles that deliver high concentrations of chemotherapy to the brain while minimizing systemic side effects. Paul is able to go back to his busy life after these procedures. The tumor returns a couple of times, and he is retreated with the same approach. While the tumor will eventually take Paul’s life, focused ultrasound therapy could transform a fatal condition into one that is chronic, but manageable.

Focused ultrasound uses ultrasonic energy guided by real-time imaging to treat tissue deep in the body without incisions or radiation. Multiple intersecting beams of ultrasound are directed and concentrated on a target, much like a magnifying glass can focus multiple beams of light on a single point. Where each individual beam passes through the tissue, there is no effect. But, at the focal point, the convergence of the beams of focused ultrasound energy results in many important biological effects depending on the nature of the tissue and the ultrasound parameters.

“John has been a board member and steadfast supporter of our foundation for years. We are fortunate to have such a noteworthy advocate helping to spread the word about this game-changing therapy,” said Neal F. Kassell, M.D., chairman of the Focused Ultrasound Foundation. “He wants to help ensure that focused ultrasound is part of our future. Though in its infancy, there is great potential for this technology to improve quality of life and decrease cost of care. But progress is too slow, and we want to help make it available sooner to help as many people as possible.”

Grisham wrote "The Tumor" to raise awareness and funds to help the Focused Ultrasound Foundation to accelerate the development and adoption of the technology to improve the lives of millions of people with serious medical disorders. While the book is free, he encourages the public to support the foundation’s programs for research, education and advocacy.

Today, focused ultrasound is approved in the United States to treat uterine fibroids, reduce pain from bone metastases and treat the prostate. Different systems are approved to treat 16 diseases in regions around the world. The technology is in various stages of research and development for more than 50 diseases, including Parkinson’s, Alzheimer’s, hypertension and tumors of the brain, liver, breast and pancreas.

For more information: www.thetumor.org

Related Content

Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
RaySearch Launches RayCare Oncology Information System

Image courtesy of RaySearch Laboratories

Technology | Oncology Information Management Systems (OIMS) | December 22, 2017
RaySearch announced the first release of RayCare, a new oncology information system (OIS) designed to connect the...
RaySearch Releases RayStation 7 Radiotherapy Treatment Planning System
Technology | Treatment Planning | December 19, 2017
RayStation 7, the latest release of RaySearch’s radiation therapy treatment planning system, adds new functionality and...
Overlay Init